Johnny John
Chief Tech/Sci/R&D Officer chez DELCATH SYSTEMS, INC.
Fortune : 10 022 $ au 31/03/2024
Profil
Johnny John is currently working as the Senior VP-Clinical Development & Medical Affairs at Delcath Systems, Inc. Prior to his current position, he worked at inVentiv Health, Inc. as Operations-Clinical Trials from 2004 to 2012.
Dr. John completed his undergraduate and doctorate degrees at Mangalore University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
DELCATH SYSTEMS, INC.
0,01% | 12/06/2023 | 2 101 ( 0,01% ) | 10 022 $ | 31/03/2024 |
Postes actifs de Johnny John
| Sociétés | Poste | Début |
|---|---|---|
| DELCATH SYSTEMS, INC. | Chief Tech/Sci/R&D Officer | 19/03/2012 |
Anciens postes connus de Johnny John
| Sociétés | Poste | Fin |
|---|---|---|
inVentiv Health, Inc.
 inVentiv Health, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health, Inc. provides outsourced product development and commercialization services. It operates its business through the following segments: Clinical and Commercial. The Clinical segment clinical offers a continuum of services spanning phases I-IV of clinical development to the changing needs of pharmaceutical, biotechnology, diagnostic and medical device clients. The Commercial segment consists of selling solution services, communications, patient outcomes and consulting service offerings. The company was founded in 1999 and is headquartered in Burlington, MA. | Corporate Officer/Principal | 01/01/2012 |
Formation de Johnny John
| Mangalore University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DELCATH SYSTEMS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
inVentiv Health, Inc.
inVentiv Health, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health, Inc. provides outsourced product development and commercialization services. It operates its business through the following segments: Clinical and Commercial. The Clinical segment clinical offers a continuum of services spanning phases I-IV of clinical development to the changing needs of pharmaceutical, biotechnology, diagnostic and medical device clients. The Commercial segment consists of selling solution services, communications, patient outcomes and consulting service offerings. The company was founded in 1999 and is headquartered in Burlington, MA. | Commercial Services |
